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Abstract
Bacteroides fragilis is an opportunistic pathogen which can cause life threatening infections in humans and animals. The
ability to adhere to components of the extracellular matrix, including collagen, is related to bacterial host colonisation.
Collagen Far Western analysis of the B. fragilis outer membrane protein (OMP) fraction revealed the presence two collagen
adhesin bands of ,31 and ,34 kDa. The collagen adhesins in the OMP fraction were separated and isolated by two-
dimensional SDS-PAGE and also purified by collagen affinity chromatography. The collagen binding proteins isolated by
both these independent methods were subjected to tandem mass spectroscopy for peptide identification and matched to a
single hypothetical protein encoded by B. fragilis NCTC 9343 (BF0586), conserved in YCH46 (BF0662) and 638R (BF0633) and
which is designated in this study as cbp1 (collagen binding protein). Functionality of the protein was confirmed by targeted
insertional mutagenesis of the cbp1 gene in B. fragilis GSH18 which resulted in the specific loss of both the ,31 kDa and the
,34 kDa adhesin bands. Purified his-tagged Cbp1, expressed in a B. fragilis wild-type and a glycosylation deficient mutant,
confirmed that the cbp1 gene encoded the observed collagen adhesin, and showed that the 34 kDa band represents a
glycosylated version of the ,31 kDa protein. Glycosylation did not appear to be required for binding collagen. This study is
the first to report the presence of collagen type I adhesin proteins in B. fragilis and to functionally identify a gene encoding a
collagen binding protein.
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Introduction
Bacteroides fragilis, a Gram negative, rod-shaped obligately
anaerobic bacterium, is a commensal inhabitant of the human
colon, assisting with digestion and the development of the host
immune system [1]. However, under certain circumstances, it can
become an opportunistic pathogen causing abscess formation, soft-
tissue infections, and bacteraemia [2]. Treatment of these life-
threatening infections is complicated by the emergence of
antibiotic drug resistance in the clinical setting [3] and, therefore,
alternative novel therapeutic targets, such as factors which
enhance bacterial virulence, need to be investigated to assist in
drug design.
Potential B. fragilis virulence factors include capsular polysac-
charides, neuraminidases (sialidases), haemolysins and enterotoxins
(B. fragilis toxin; BFT) [2]. When a breach in the epithelium of the
human intestine occurs, B. fragilis comes into contact with the host
extracellular matrix (ECM). The ability of the bacterium to interact
with components of the ECM is thought to play a major role in
pathogenesis involving both adhesion to and degradation of these
components during colonization and tissue invasion. The host ECM
is an intricate network of biologically active macromolecules
underlying the epithelial and endothelial cells. It surrounds
connective tissue cells serving a structural function and participating
in cellular adhesion, migration, proliferation and differentiation [4].
The ECM also serves as a substrate for the attachment of
microorganisms [5], a crucial first step in the infective process.
This attachment is mediated by microbial surface components
which can recognise adhesive matrix molecules (MSCRAMMs) [5].
Inhibition of the adhesive properties of organisms has been
examined as a potential therapeutic method, and strategies for
preventing adhesion have been reviewed by Barczak and Hung [6].
For example, in Gram negative bacteria, the inhibition of the
formation of pili and fimbriae has been shown to block adhesion [7].
The macromolecules that make up the ECM are divided into four
main classes, namely glycoproteins, proteoglycans, elastin and
collagens. B. fragilis has been shown to interact with a number of
these components including the glycoproteins laminin and fibro-
nectin, and the proteoglycan fibrinogen [8,9,10,11].
Collagen is the major component of the ECM and is the most
abundant protein in mammals, accounting for 25 to 33% of all
proteins [12]. The ability of bacteria to interact with it is,
therefore, important for both commensals and pathogens.
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Adhesins with the ability to bind single or multiple forms of
collagen have been described in bacteria [5]. The Cna, collagen
binding protein mediates the adhesion of Staphylococcus aureus to
different collagen types [13], and the virulence factor YadA, found
in pathogenic Yersinia spp. [14], binds to various collagen types (I,
III, IV and V) as well as the ECM proteins laminin and
fibronectin.
There is limited published information relating to the interac-
tions of B. fragilis with collagen. Szoke et al. [15] demonstrated
collagen type I binding associated with cell surface proteinaceous
receptors. Fifteen of 24 B. fragilis isolates from infected sites and 9
out of the 13 of strains isolated from faecal material were able to
adhere to collagen type I [10] indicating that adhesion was strain
specific. This was supported by the work of Galvão et al. [16] who
showed that 87% of the B. fragilis clinical isolates studied could
bind collagen. In that study, B. fragilis strain GSH18 demonstrated
the highest level of collagen binding. We now report the functional
characterisation of a glycoprotein collagen adhesin from B. fragilis
GSH18.
Materials and Methods
Bacterial Strains, Plasmids and Growth Conditions
Bacterial strains and plasmids are shown in Table 1. B. fragilis
was routinely cultured in supplemented Difco brain heart infusion
medium (BHIS), and grown under anaerobic conditions [17]. B.
fragilis transconjugants were cultured on BHIS agar including
gentamicin (200 mg/ml) and erythromycin (10 mg/ml). B. fragilis
strains carrying the plasmid pCMF92 were grown in the presence
of erythromycin (10 mg/ml). Escherichia coli strains were grown,
aerobically, in Luria-Bertani (LB) broth or agar at 37uC [18] and
supplemented with ampicillin (100 mg/ml) to maintain plasmids.
Membrane Protein Sample Preparation
B. fragilis GSH18 cells grown for 16 h to late log/early
stationary phase, were collected and disrupted by sonication using
a Misonic sonicator 3000 at a power output of 3 W for 5 rounds of
30 s. The outer membrane proteins (OMP) were then extracted by
the method of the Pauer et al. [9,19]. OMPs were resuspended in 1
X PBS (pH 7.4). For the purification of the His-tagged proteins
(see later), crude membrane (CM) samples were used. These were
obtained before the 0.3% Sarcosyl treatment step of the OMP
extraction technique. The protein concentrations were determined
using Bio-Rad Protein Assay Dye Reagent Concentrate according
to the manufacturer’s instructions (Bio-Rad Laboratories, cat #
1500-0006) using bovine serum albumin (BSA) as a standard.
Collagen Far Western Blot
An adaption of the methods of Esmay et al. [20] and Ferreira
et al. [8] was used. The OMP sample (75 mg) was mixed in a 1:1
ratio with 2X SDS gel loading buffer (0.125 M Tris-HCl [pH 6.8],
4% SDS, 20% glycerol, 0.002% bromophenol blue) and incubated
at room temperature for 10 min prior to electrophoresis on
duplicate gels (10% SDS (w/v) polyacrylamide gel without b-
mercaptoethanol) [21]. PageRulerTM Prestained Protein Ladder
(Fermentas, #SM0671) was used as the molecular weight
standard. One gel was stained with Coomassie brilliant blue or
Acqua stain (Acqua Science), and the other was transferred on to a
nitrocellulose membrane using the Trans-BlotH SD DNA/RNA
Blotting Kit (Bio-Rad) as per the manufacturer’s instructions. A
minimum of three biological repeats were performed for each
experiment.
The nitrocellulose blots were blocked overnight in blocking
buffer (1X PBS buffer, pH 7.2 with 1.5% BSA [Roche, 10 735 086
001] and 5% skim milk) followed by 3 h incubation at
approximately 23uC in PBS-B-T buffer (1X PBS, pH 7.2; 1.5%
BSA; 0.1% Tween) containing 20 mg/ml of collagen Type I from
calf skin (Elastin Products Company Inc.). The membranes were
immunostained with anti-collagen type I (Rabbit) antibody
(Rockland, 600-401-103-0.1) and peroxidase conjugated anti-
rabbit IgG (Goat) antibody (Rockland, 611-1302; or Gene Tex,
GTX77060) as primary and secondary antibodies, respectively.
TMB Membrane Peroxidase substrate (KPL, 50-77–18) or Pierce
ECL Western Blotting Chemiluminescent Substrate (Thermo
Scientific Product # 32106) was used for development of the
membranes. In order to confirm the specificity of the anti-collagen
type I (Rabbit) antibody a control blot was exposed to the antibody
without the collagen binding step.
Table 1. Description of bacterial strains and plasmids.
Strain/Plasmid Genotype/phenotypea Source/reference
Plasmids
pGERM pUC19-based suicide vector [28]
pGERMcbp1-int pGERM containing cbp1 internal fragment This study
pCMF92 pCMF6 expressing Cbp1 with a C-terminal His-tag [34]
Strains
Bacteroides fragilis
GSH18 Clinical isolate, GentR, TetR [16]
GSH18 cbp12 GSH18 derivative, cbp12, GentRErmR This study
NCTC9343 pCMF92 Wildtype strain expressing Cbp1His; ErmR [34]
Dgmd-fclDfkp pCMF92 Glycosylation deficient mutant expressing Cbp1His; ErmR [34]
Escherichia coli
S17-1 RP4-2-Tc::Mu aph::Tn7recA2, StrepR [37]
S17-1 pGERMcbp1-int RP4-2-Tc::Mu aph::Tn7recA2, StrepRAmpR This study
GentR, ErmR, StrepR, and AmpR denote resistance to gentamicin, erythromycin, streptomycin and ampicillin, respectively
doi:10.1371/journal.pone.0091141.t001
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Collagen Affinity Chromatography
Collagen affinity purification of collagen binding OMP proteins
was performed using a cyanogen bromide (CnBr) activated
sepharose matrix (Sigma, C9142) coupled with collagen Type I
prepared as per the manufacturer’s instructions. The OMP
fraction of B. fragilis GSH18 (3-7 mg in 10 ml 1 X PBS) was
passed three times through the collagen affinity column which was
then washed with 20 ml 1 X PBS. The bound proteins were eluted
in a step-wise manner with 2 ml of 0.15, 0.3, 0.6, 1, 1.5, and 2 M
NaCl solutions. The protein content of 200 ml of the OMP sample,
and 2 ml of each elution fraction were precipitated using 100%
(w/v) Trichloroacetic acid (TCA) [22]. Each protein pellet was
resuspended in 20 ml of 1X SDS-PAGE loading dye and examined
on SDS –polyacrylamide gel (10% (w/v) without b-mercaptoeth-
anol.
Two-dimensional (2D) Gel Electrophoresis
OMPs (250 mg) were TCA precipitated by the method of
Isaacson et al. [22]. Solubilisation and sample application on to the
ReadyStripTM IPG strips (BIORAD) were done according to the
manufacturer’s instructions. Iso-electric focusing (IEF) was per-
formed in a Protean IEF Cell (Bio-Rad) as follows: 250 V, 15 m;
2500 V, 2 h30 m; 4000 V, 20 000 Vh. The second dimension was
done on a 10% SDS polyacrylamide gel. Four replicate gels were
run for analysis and protein spot picking. Duplicate gels were run
for Far Western analysis.
LC MS/MS Analysis of Putative Adhesins
Protein bands excised from the affinity purification gels and
protein spots excised from the 2-D PAGE gels were analyzed by
tandem mass spectrometry (LC MS/MS) (Yale Cancer Centre
Mass Spectrometry Resource & W.M. Keck Foundation Biotech-
nology Resource Laboratory, New Haven, Connecticut, USA).
The proteins were identified against the NCBI bacterial database
using the MASCOT program (www.matrixscience.com), where
protein scores greater than 82 were significant (p,0.05).
Bioinformatic analysis of the cbp1 gene cluster
Bioinformatic analysis of the predicted protein sequence of the
B. fragilis NCTC 9343, cbp1 gene (BF0586) was performed using
Phyre2 (Protein Homology/AnalogY Recognition Engine), an
automatic fold recognition server for predicting the structure and/
or function of protein sequences [23]. Clustal Omega was used to
generate the multiple sequence alignments [24,25]. The predicted
protein sequence of the cbp1 gene product was analysed using the
LipoP 1.0 and GlycoPP servers [26,27].
DNA Techniques and Construction of B. fragilis cbp1-
mutant
Genomic DNA of B. fragilis GSH18 was extracted using the
method of Steffens et al. [17]. Plasmids were extracted from E. coli
strains using the BioSpin Plasmid Extraction Kit (BioFlux). All
PCR analyses were performed using Kapa ReadyMix (Inqaba
Biotech) as per manufacturers’ instructions, and the thermal
cycling was performed using a GeneAmpH PCR system 9700
(Applied Biosystems). The standard PCR parameters used
consisted of an initial 5 min denaturation step at 95uC, followed
by 25 cycles of denaturation for 30 sec at 95uC, annealing for
30 sec at primer pair specific temperatures (Table 2), and
elongation at 72uC for time periods specific to target products,
followed by a final 5 min elongation step at 72uC.
For construction of the B. fragilis GSH18 cbp12 insertional
mutant, a 0.339 kb fragment corresponding to an internal region
of the cbp1 gene, beginning at base 43 and terminating at base 381
was PCR amplified using the primers BF0586-Fstop and BF0586-
Rstop (Table 2). The product was blunt cloned into the SmaI site of
the suicide vector pGERM according to standard protocols [18] to
generate pGERMcbp1-int. The recombinant plasmid was trans-
formed into E. coli S17-1 competent cells and transferred into B.
fragilis GSH18 by conjugation [28]. Confirmation of mutagenesis
was done by PCR of erythromycin and gentamicin resistant B.
fragilis transconjugant colonies, using primers M13R with BF0586-
F2PET, and M13F with BF0586-R2PET (Table 2), followed by
sequencing of the PCR products (Macrogen Inc., Seoul, Korea).
Purification of His-tagged Proteins Expressed in Wild-
Type B. fragilis 9343 and its Glycosylation Deficient
Mutant (Dgmd-fclDfkp)
The His-tagged proteins expressed in each strain were purified
from the respective crude membrane extracts (CMs) as follows. A
5 ml Hitrap chelating column (GE Healthcare) was charged with
nickel and equilibrated with 10 column volumes of buffer A (0.1 M
sodium phosphate buffer, pH 8.0, 500 mM NaCl, 8 M urea). The
protein sample was filtered through a 0.45 mm filter and loaded
onto the column. Once the OD280 returned to baseline the column
was washed with buffer B (0.1 M sodium phosphate, pH 6.3,
500 mM NaCl, 8 M urea). The bound protein was eluted using a
linear gradient of 15 column volumes to 50% buffer C (0.1 M
sodium phosphate, pH 6.3, 500 mM NaCl, 8 M urea, 500 mM
Imidazole) and a step to 100% buffer C which was maintained for
5 column volumes.
Whole cell collagen adhesion assays
The collagen adhesion assays were performed based on a
previously described method [8]. Briefly, 20 mg/ml of collagen
Type I from calf skin (Elastin Products Company Inc.) in PBS was
immobilized on glass cover slips for 1 hour. The cover slips were
subsequently washed with PBS containing 0.1% (w/v) Bovine
Serum albumin (BSA) (0.1% PBSB) to remove unbound collagen.
Finally, the cover slips were blocked with 2% PBSB for another
hour. Cover slips coated with 2% BSA were used as a control.
Suspensions of either the B. fragilis GSH18 wild-type, or the cbp12
mutant, at an OD600 nm of approximately 0.6 were prepared using
pre-reduced PBS. Aliquots (200 ml) of each strain were added to
the cover slips and allowed to interact anaerobically for 60 min at
37uC. After the incubation period, the cover slips were washed
with PBS and fixed with methanol for 5 min, and then washed
again with PBS. The bound bacterial cells were then stained with
0.1% crystal violet. Each experiment was carried out in triplicate
(3 biological replicates) with 3 technical repeats each. The
adherence of the bacteria to the cover slips was determined by
counting 10 random fields of view of each cover slip (10006
magnification). Data are presented as the mean 6SEM (Standard
Error of the mean). The Student t-test was used for statistical
analysis and values with p,0.05 were considered significant.
Results and Discussion
Collagen Adhesins of the B. fragilis Outer Membrane
The ability of B. fragilis whole cells to adhere to collagen has
been previously demonstrated by us and others [16,15,10], but the
cell surface structures responsible for this adhesion were not
known. In order to identify such proteins, the collagen adhesion
profile of the outer membrane proteins (OMPs) of the B. fragilis
clinical isolate GSH18 was examined by collagen Far Western
analysis (Lane 2, Fig. 1). This showed the production of putative
collagen adhesins of approximately ,31 and ,34 kDa. Two
Bacteroides fragilis Collagen Adhesins
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independent methods were used in parallel to isolate and separate
these. The first method, affinity chromatography, allowed for the
enrichment of the putative adhesins (Fig. 2A). Although the
presence of both the ,31 and the ,34 kDa putative adhesins
could be clearly seen in the Far Western analysis of the eluted
fractions (Fig. 2B, lanes 2 to 5) only a ,31 kDa protein band
appeared more intensely in the coomassie stained gel (Fig. 2A,
lanes 2 to 5). This band eluted best using 1 M NaCl solution
(Fig. 2A, lane 3) and was excised from the protein gel and
subjected to LC MS/MS analysis.
The second method used to isolate putative collagen binding
OMPs was 2D-PAGE. The aim here was to separate out all the
proteins of the OMP fraction, identify those which could bind
collagen and then excise single protein spots for protein
identification. In order to observe the full spectrum of possible
OMP adhesins in the 2D-PAGE experiments, a pI range of 3 to 10
was used. Figures 3A and B show an example of one of the 2D-
PAGE gels and the corresponding Far Western blots. The
Coomassie stained gels were analyzed, using the PDQuest
Software version 7.4.0 (Bio-Rad), in order to match particular
protein spots across the various gels. A number of protein spots
able to bind collagen were observed. These were predominantly
found in an area between approximately pI 5.7 and 7.3, with a size
range between 25 and 54 kDa. A very intense area of collagen
Table 2. Description of PCR primers.
Name Primer *Hyb T6 Fragment size Description
BF0586-Fstop 59-GCTTAGTGTAACGGCCTGG-39 52.1uC 0.339 kb Primer pair amplifies an
internal fragment of BF0586
of B. fragilis NCTC 9343 gene
homologue; cbp1. Stop
codons are bolded with
altered bp underlined.
BF0586-Rstop 59-ACTCAACAGCCTTCTACAGC-39 50.4uC
M13F 59-CGCCAGGGTTTTCCCAGTCACGAC-39 60.5uC variable Universal primers [38]
M13R 59-GAGCGGATAACAATTTCACACAGG-39 53.7uC
BF0586-F2PET 59-AAATGTAATCCCATGGAAAAGTTAGC-39 (NcoI) 51.0uC 0.87 kb Primer pair amplifies the full
length BF0586 of B. fragilis
NCTC 9343 gene homologue;
cbp1. Restriction enzyme sites
(in brackets) are bolded with
altered bp underlined.
BF0586-R2PET 59-TTACTCGAGTTGGATAACCAAATAC-39 (XhoI) 50.7uC
*Hyb Tu. Hybridization temperature.
doi:10.1371/journal.pone.0091141.t002
Figure 1. Collagen Far Western of the outer membrane protein
fraction (OMP) of B. fragilis GSH18. Lanes: (M): PageRulerTM
#SM0671; (1) Coomassie stained gel, (2) Far Western.
doi:10.1371/journal.pone.0091141.g001
Figure 2. Affinity purification of collagen adhesins of the outer
membrane protein fraction (OMP) of B. fragilis GSH18: (A)
Coomassie stained gel, (B) Far Western. Lanes: (M): PageRulerTM
#SM0671, (1): OMP, (2–5): Elutions with 0.6, 1, 1.5 and 2 M NaCl
respectively.
doi:10.1371/journal.pone.0091141.g002
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binding could be seen at approximately 28 kDa (indicated by the
box in Fig. 3B). Unfortunately we were not able to clearly see
corresponding spots in the Coomassie stained gels (Fig. 3A) and
these proteins could not be analysed further using this method. It is
possible that these proteins have been post-translationally modified
to such an extent that renders them recalcitrant to staining by
Coomassie. Future studies to identify these proteins could make
use of commercially available fluorescent dyes such as Flamingo
PinkTM (BioRad) and Sypro RubyTM (Invitrogen), which are more
sensitive than Coomassie, and can stain even glycosylated proteins
efficiently, and require little or no pre-treatment before being
subjected to mass spectrometric analysis. Of the other collagen
binding spots observed, those labelled 1 to 4 in Figures 3B
appeared to correspond to coomassie stained spots labelled in the
same manner. These spots were in the correct size range for the
bands seen in the 1D gels and were, therefore, excised from the
protein gels and subjected to LC MS/MS analysis.
Identification of a B. fragilis collagen adhesin protein
The LC MS/MS analysis of the affinity purified ,31 kDa
sample showed the highest scoring candidate to be a hypothetical
protein, BF0586, of B. fragilis NCTC9343. Interestingly protein
spots 1, 2 and 3, isolated independently in the 2D-PAGE
experiment, also had this hypothetical protein as the highest
scoring candidate. Spot 4 had this protein only as its third highest
scoring candidate, with its highest scoring candidate being a
putative succinate dehydrogenase/fumarate reductase iron-sulfur
subunit (BF4341, of B. fragilis NCTC9343). The BF0586 gene, to
be referred to from this point onwards as cbp1 (collagen binding
protein), is predicted to encode a protein with a calculated
molecular mass of 31.6 kDa. This is in the correct size range for
the smaller of the putative adhesin bands (Fig 1) and for the 2D
spots observed in this study (Fig 3A). This gene was, therefore,
explored further as a possible candidate for encoding this observed
collagen binding protein.
This gene is conserved in the genomes of the three published B.
fragilis genome sequences. The BF0586 gene of B. fragilis NCTC
9343 [29] corresponds to the YCH46 [30] ORF BF0662, and
ORF BF638R0633 of strain 638R [31]. The cbp1 gene is
annotated in the genome (NCBI) as encoding a 31.6 kDa
hypothetical protein with a predicted Smc, chromosome segrega-
tion domain (e-value of 2.20e-07) and no homology to any
adhesin-like proteins. Attempts to further analyse the predicted
protein sequence of the putative Cbp1 protein using the automatic
fold recognition server Phyre2 did not yield any further useful
information.
Figure 3. Comparison of collagen-binding proteins from the outer membrane of B. fragilis GSH18 wild-type and B. fragilis GSH18
cbp12 mutant by two-dimensional gel electrophoresis. OMPs were separated in the first dimension on precast IPG strips (pH 3–10, indicated
by the arrow) followed by separation in the second dimension on 10% SDS-PAGE gels: (A and C) Coomassie stained gels of the wild-type and cbp12
respectively; (B and D) Collagen Far Western of proteins from 2D-gels of the wild-type and cbp1- respectively;. M: PageRulerTM #SM0671. Further
details discussed in text.
doi:10.1371/journal.pone.0091141.g003
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The LipoP 1.0 server indicated that Cbp1 is a putative
lipoprotein (Fig 4). The presence of a signal sequence, as well as
a lipobox motif strongly supports this prediction [32]. The signal
sequence is predicted to be found from amino acid position 1 to 16
with a putative signal peptidase type II (SpII) site between S16 and
C17. A characteristic lipobox consensus sequence, [LVI][AST-
VI][GAS]C, is present with C17 being the predicted conserved
site of acylation. According to Kovacs-Simon and colleagues [32]
the thiol group of this cysteine residue of lipoproteins receives a
diacylglyceryl moiety which known to anchor the proteins to the
membrane. In Gram negative bacteria such as B. fragilis, the
mature lipoprotein also has an additional fatty acid that is linked to
the N-terminus of the same cysteine residue. Acylation is not only
used to tether proteins to the bacterial cell membranes but is also
important for virulence. Lipoproteins are involved in host-
pathogen interactions which range from initiation of inflammation
to cell surface adhesion. These characteristics are relevant for the
proposed role of Cbp1 as a cell surface adhesin and are consistent
with our observation that this protein is found in the membrane
fraction of B. fragilis.
Glycosylation is another post-translational modification (PTM)
that has been shown to be an important feature of proteins
involved in pathogenesis. These include cell surface molecules
such as adhesins and the protein subunits of pili, structures known
to be involved in adhesion in B. fragilis [33,2]. Several mutants of
bacterial genes responsible for the glycosylation of proteins have
been shown to have reduced adhesion ability [33]. The recently
developed GlycoPP 1.0 server is an updated tool for the prediction
of glycosites of prokaryotic glycoproteins which incorporates the
work of Fletcher and colleagues on the characteristics of O-
glycosylation in B. fragilis [27,34]. These sources were use to detect
the putative O-glycosylation sites D32, S33 and L34 of Cbp1
which are consistent with B. fragilis O-glycosylation motif(s) D(S/
T)(A/I/L/M/T/V). Interestingly Fletcher and colleagues identi-
fied Cbp1 (BF0586) as a putative glycoprotein using this
bioinformatics prediction tool, and also determined that the
protein is glycosylated using immuno-detection with anti-glycan
antiserum. In their study, however, they suggest a putative role for
the protein in chromosomal segregation.
Insertional inactivation of cbp1 and functional
confirmation
In order to test whether Cbp1 (BF0586) was responsible for the
observed collagen adhesion seen in B. fragilis by Far Western
analysis, insertional mutagenesis was used to disrupt the gene
encoding it. The disruption was confirmed by PCR of the
transconjugant strain with primers external to the gene (BF0586-
F2PET and BF0586-R2PET) in combination with M13 primers
specific to the suicide vector used (Table 2), and the resultant
products were sequenced (data not shown).
A comparison of the collagen adhesin profile of the OMPs of B.
fragilis GSH18 cbp12 mutant, with that of the wild-type strain, was
performed using both one- and two-dimensional (1D and 2D) gel
electrophoresis (Figures 5 and 3 respectively). The collagen Far
Western analysis of these revealed that the B. fragilis cbp1 mutant
lacked both the ,31 and ,34 kDa collagen binding bands on the
1D gel (lane 2 of Figure 5 B) as well as all 4 spots previously chosen
for analysis from the 2D gels (spots 1 to 4 of Figure 3 D). It was not
possible to see a distinct difference between the B. fragilis wild-type
and cbp12 mutant in the coomassie stained protein gels of the 1D
protein gels, however, an analysis of 2D gels using the PDQuest
Software version 7.4.0 (Bio-Rad) showed that only spot 1, was
clearly absent in the mutant (Fig. 3C). It remains unclear why spots
2 to 4 on the coomassie gels were still present in the mutant but it
is possible that in the wild-type, differentially modified forms of
Cbp1 may have co-migrated with other proteins also present in the
same position as these spots.
These results show that the product of the cbp1 gene is
responsible for the production of the two collagen binding protein
bands observed in the 1D- Far Western blots. The size of the
smaller band (,31 kDa) agrees with the predicted protein size of
31.6 kDa (unmodified pre-protein) and the predicted size of
29.98 kDa of the protein with the cleaved signal sequence. The
variation of sizes and pI’s observed for the Cbp1 in the 1D- and
2D analyses may, therefore, be a reflection of the presence of
Cbp1 in various stages of post-translational modification, including
the removal of the signal sequence, and the addition of the
predicted lipid and sugar moieties discussed previously. The work
of Fletcher and colleagues [34] showed that the glycosylated forms
of the B. fragilis proteins studied all showed an increase in apparent
molecular weight. Interestingly all the variations of the protein
observed in the present study bound collagen so it was not clear if
glycosylation itself influenced this function. To validate that the
cbp1 gene is responsible for the production of the ,31 and
,34 kDa collagen binding proteins that are produced by the wild
type and not by the cbp12 mutant strains, a His-tagged form of
Cbp1 (Cbp1His) was purified and subjected to collagen Far
Western analysis.
Figure 4. Predicted protein sequence of the pre-protein version of Cbp1 with the putative post-translation modification sites and
regions of interest indicated. A signal peptide was predicted by LipoP 1.0 to be found from amino acid position 1 to 16 (underlined) with a
putative signal peptidase type II (SpII) site between S16 and C17. A characteristic lipobox consensus sequence, [LVI][ASTVI][GAS]C, is indicated by the
boxed amino acids in bold font with C17 being the predicted conserved site of acylation. The sequence shaded in black and in white font indicates
the B. fragilis O-glycosylation motif(s) D(S/T)(A/I/L/M/T/V).
doi:10.1371/journal.pone.0091141.g004
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Binding of Collagen by the purified Cbp1His
The target proteins were expressed in the B. fragilis hosts to
ensure that any relevant post-translational modifications (PTMs)
could be completed. This is important since heterologous
expression in E. coli is not always effective in achieving the same
PTMs as the native host [35]. The Cbp1His was purified by nickel
affinity chromatography from extracts from both wild-type NCTC
9343 (WT Cbp1His) and the glycosylation deficient mutant, Dgmd-
fclDfkp (DD Cbp1His) [34]. Figure 6A shows that the purified
Cbp1His is present chiefly as a ,35 and ,32 kDa band in the WT
Cbp1His and as a ,32 kDa band in the DD Cbp1His. The
,35 kDa band can, therefore, be interpreted to represent the
glycosylated form of the protein. Both forms of the protein can,
however, bind collagen (Fig. 6B). This result supports the data
shown in Figure 5B where the mutation in the cbp1 gene results in
the loss of both bands.
It is important to note that two smaller his-tagged protein
fragments of ,27 and ,29 kDa (Fig 6A) were co-purified with the
target proteins that during the nickel purification process. All the
His-tagged proteins were analysed by LC MS/MS and it was
revealed that the fragments smaller than ,32 kDa were truncated
versions of the Cbp1His protein. The truncated fragments were
shown to lack the N-terminal regions down to about position R73
(Fig 4), whereas the ,32 and ,35 kDa extended to about position
A29. This would account for the presence of the C-terminal his-
tag observed in the smaller fragments (Fig 6A) and would explain
why these fragments were co-purified with the target proteins. The
reason for the occurrence of the truncated fragments is not clear.
The apparent lack of collagen adhesion by the fragments may be
due to the species being present at low concentrations. Alterna-
tively, the collagen binding domain could be located at the N-
terminal end of the protein. Future investigations will determine
which regions of the protein are essential for collagen binding, by
analysing collagen adhesion using N-terminal truncated versions of
Cbp1.
Whole cell collagen adhesion assays
To analyze the contribution of Cbp1 to the ability of whole cells
of B. fragilis to adhere to collagen type I in vitro, the B. fragilis GSH
18 wild-type and cbp12 mutant strains were allowed to adhere to
collagen type I immobilized on glass coverslips. The number of
bound bacterial cells was then determined. This revealed that
there was no significant difference between the ability of the whole
cells of B. fragilis GSH 18 wild-type and cbp12 mutant to bind
collagen (p-value = 0.464) (Fig. 7). This indicates that more than
one surface component enables Cbp1 B. fragilis to bind to collagen.
This is not altogether unexpected as adhesion to ECM compo-
nents is often achieved by the contribution of several cell surface
components. It is interesting to note that Cbp1 was associated with
the outer membrane of the bacterium, and adhesion of B. fragilis to
host cells has been associated with outer membrane vesicles and
surface polysaccharides [36]. Future work should not only aim to
identify the other collagen binding proteins already observed in
this study, but also investigate the role of the extracellular and cell
associated components mentioned above, together with other
structures known to be involved with bacterial adhesion, such as
fimbriae [7]. Furthermore it would be of great interest to
Figure 5. Collagen Far Western blot of B. fragilis GSH18 wild-
type and cbp12 mutant. (A) Coomassie stained gel, (B) Far Western.
Lanes: (M): PageRulerTM #SM0671; (1) wild-type OMP; (2) cbp1-mutant
OMP.
doi:10.1371/journal.pone.0091141.g005
Figure 6. Analysis of the purified Cbp1His proteins produced
from wildtype B. fragilis 9343 and the glycosylation deficient
mutant B. fragilis 9343 (Dgmd-fclDfkp). (A) His-Tag Western (B)
Collagen Far Western. Lanes: (M): PageRulerTM #SM0671; (1) Cbp1His
from wildtype B. fragilis NCTC 9343; (2) Cbp1His from B. fragilis Dgmd-
fclDfkp.
doi:10.1371/journal.pone.0091141.g006
Figure 7. Adhesion of B. fragilis GSH18 wild-type and cbp1-
mutant to collagen. Experiments performed in triplicate. Data are
presented as the mean 6SEM (Standard Error of the mean). The Student
t-test was used for statistical analysis and values with p,0.05 were
considered significant.
doi:10.1371/journal.pone.0091141.g007
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investigate the relationship of Cbp1 and B. fragilis cells in general
to collagen proteins other than Type I collagen.
Conclusion
The increasing incidence of antibiotic resistance in the
important human opportunistic pathogen, B. fragilis, has prompted
the search for new therapeutic targets such as virulence factors [6].
In this study, a collagen binding glycoprotein, designated Cbp1,
was identified. Its function was confirmed by the loss of the
relevant B. fragilis collagen adhesin bands/spots following inser-
tional inactivation of the cbp1 gene in the clinical isolate B. fragilis
GSH18, as well as by the ability of purified recombinant Cbp1His
to bind collagen. This enabled the assignment of function as an
adhesin to the ORF BF0586 in the type strain NCTC9343.
A pure substrate based in vitro binding system indicated
redundancy with respect to collagen binding, as the cbp12 mutant
continued to demonstrate significant collagen binding. Further
research into the contribution of Cbp1 to the ability of the
pathogen to bind and invade host cells in vitro, as well as in vivo
assessment of virulence and immune response, will determine the
functional role of this novel adhesin.
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